-
Curr Neurol Neurosci Rep · Feb 2011
ReviewImplications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
- Megan M Donohue and David L Tirschwell.
- Department of Neurology, Harborview Medical Center, 325 9th Avenue, Box 359775, Seattle, WA 98104, USA. donohue@u.washington.edu
- Curr Neurol Neurosci Rep. 2011 Feb 1; 11 (1): 52-60.
AbstractOur knowledge of the pharmacogenetics of warfarin and clopidogrel continues to expand as we learn more about the individual genetic variations that contribute to the drugs' efficacy and toxicity. We aim to review the recent developments in the field and discuss the clinical implications for the treatment of ischemic stroke patients. Despite recent advances, there is still insufficient data to suggest that routine genetic testing improves outcomes in patients treated with warfarin or clopidogrel for prevention of stroke.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..